Exclusive: ACR Convergence 2024| Focus Rheums

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

Potential Biomarker for APS Identified

  |  

Lara C. Pullen, PhD, is a medical writer based in the Chicago area.

Reference

ADVERTISEMENT
SCROLL TO CONTINUE
  1. Artim-Esen B, Smoktunowicz N, McDonnell T, et al. Factor Xa mediates calcium flux in endothelial cells and is potentiated by IgG from patients with lupus and/or antiphospholipid syndrome. Sci Rep. 2017 Sep 7;7(1):10788. doi: 10.1038/s41598-017-11315-9.

Related Articles

    APS: What Rheumatologists Should Know about Hughes Syndrome

    The problem that dogs the work of all of those treating patients with antiphospholipid syndrome (APS) is the apparent lack of knowledge of the syndrome, both by the general public, as well as by swaths of the medical fraternity. Perhaps it was ever thus—a syndrome less than 40 years old could be described as new,…